Pharmaceutical regulatory requirements of nonregulated markets

[1]  D. Hughes,et al.  Affordable orphan drugs: a role for not‐for‐profit organizations , 2017, British journal of clinical pharmacology.

[2]  N. Ajami,et al.  Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis , 2017, Inflammatory bowel diseases.

[3]  R. Gamzu,et al.  Drug shortages in Israel: regulatory perspectives, challenges and solutions , 2017, Israel Journal of Health Policy Research.

[4]  S. Palmer,et al.  The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal. , 2017, Health technology assessment.

[5]  J. Healy,et al.  Patient complaints about hospital services: applying a complaint taxonomy to analyse and respond to complaints. , 2016, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[6]  J. Riviere,et al.  Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad , 2013 .

[7]  N. Phuong,et al.  International harmonization and national particularities of accounting , 2012 .

[8]  M. Trudeau,et al.  International variability in the reimbursement of cancer drugs by publically funded drug programs. , 2012, Current oncology.

[9]  John Stover,et al.  Towards an improved investment approach for an effective response to HIV/AIDS , 2011, The Lancet.

[10]  R. Wessel,et al.  Multilevel Regulation and the EU , 2008 .

[11]  L. Garattini,et al.  Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis. , 2007, Health policy.

[12]  Lawrence X. Yu,et al.  Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). , 2004, Advanced drug delivery reviews.

[13]  C. S. Tan,et al.  Pharmaceutical Pricing in Malaysia , 2015 .

[14]  M. Ramaiah,et al.  REGULATORY REQUIREMENTS FOR THE REGISTRATION OF GENERIC SOLID ORALS IN USA, SINGAPORE, MALAYSIA, AND THAILAND , 2014 .

[15]  D. Perrett,et al.  The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing. , 2012, Results in pharma sciences.